Log In
BCIQ
Print this Print this
 

INS1007 (formerly AZD7986)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionUndisclosed small molecule targeting dipeptidyl peptidase-1 (DPP-1; CTSC)
Molecular Target Dipeptidyl peptidase-1 (DPP-1) (CTSC)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
PartnerInsmed Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$150.0M

$30.0M

$120.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/05/2016

$150.0M

$30.0M

$120.0M

Get a free BioCentury trial today